TG Therapeutics Raises FY2026 Sales Guidance from $925.000M to $950.000M vs $942.370M Est

TG Therapeutics (NASDAQ:TGTX) raises FY2026 sales outlook from $925.000 million to $950.000 million vs $942.370 million estimate.